TY  - JOUR
AU  - Rodrigo-Faus, María
AU  - Vincelle-Nieto, Africa
AU  - Vidal, Natalia
AU  - Puente Vázquez, Javier
AU  - Saiz-Pardo Sanz, Melchor
AU  - López-García, Alejandra
AU  - Mendiburu-Eliçabe Garganta, Marina
AU  - Palao, Nerea
AU  - Baquero, Cristina
AU  - Cuesta Martínez, Ángel
AU  - Qu, Hui-Qi
AU  - Hakonarson, Hakon
AU  - Musteanu, Mónica
AU  - Reyes-Palomares, Armando
AU  - Porras Gallo, María Almudena
AU  - Bragado, Paloma
AU  - Gutierrez-Uzquiza, Alvaro
AU  - Reyes Palomares, Armando Adolfo
AU  - Bragado Domingo, Paloma
AU  - Gutiérrez Uzquiza, Álvaro
PY  - 2023
DO  - 10.1101/2023.07.20.549704
UR  - https://hdl.handle.net/20.500.14352/113457
T2  - Cancer Letters
AB  - Due to the limited effectiveness of current treatments, the survival rate of patients with metastatic castrationresistant prostate cancer (mCRPC) is significantly reduced. Consequently, it is imperative to identify novel therapeutic targets for...
LA  - eng
PB  - Elsevier
KW  - Prostate cancer
KW  - Metastasis
KW  - Invasion
KW  - PRMT7
KW  - Adhesion
TI  - CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel driver of metastasis in prostate cancer
TY  - journal article
ER  -